Status:
RECRUITING
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
Lead Sponsor:
University Hospital, Caen
Conditions:
Glioma, Malignant
Eligibility:
All Genders
18+ years
Brief Summary
MicroRNAs are small non-coding RNAs involved in the post-transcriptional regulation of genes and, consequently, of intracellular signalling pathways that govern cellular behaviour (Komatsu et al., 202...
Detailed Description
Diffuse gliomas are the most common primary tumors of the central nervous system, representing around 3,400 cases per year in France (Defossez et al., 2019). Their grade varies from 2 to 4. Whatever t...
Eligibility Criteria
Inclusion
- Major patient
- Grade 4 diffuse glioma
- Surgery in the neurosurgery department of Caen University Hospital
- Patient affiliated to a social security scheme
- Patient followed at Caen University Hospital
- No opposition from patient
Exclusion
- \- Patients who underwent biopsy (lack of material for study, limited interest of monitoring for these patients without surgical excision).
- Patients with grade 1 circumscribed glioma or grade 2 or 3 diffuse glioma.
- Other non-glial histologies, glioneuronal histology
- Minor patients
- Patient not affiliated to a social security scheme
- A minor under guardianship or protection
- Patient opposed to study
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06203496
Start Date
January 1 2024
End Date
December 31 2026
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthur Leclerc
Caen, France, 14000